SOURCE: Industrial Info Resources
SUGAR LAND, TX--(Marketwired - Oct 7, 2013) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Virtually every corner of North America will house a portion of $4.3 billion in capital and maintenance (MRO) projects for the Pharmaceutical-Biotech Industry during the fourth quarter of 2013. A recent survey taken from Industrial Info's Pharmaceutical Tracker - Online Database forecasts 235 projects with a cumulative total investment value of $4.3 billion that are ready to begin construction before the end of the year.
Other companies featured: Johnson & Johnson's (NYSE:JNJ), Novo Nordisk (NYSE:NVO)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=238674&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and nine international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.